» Articles » PMID: 33609518

Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease: Evidence Review and Practical Considerations

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2021 Feb 20
PMID 33609518
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A relationship between inhalational exposure to materials in the environment and development of interstitial lung disease (ILD) is long recognized. Hypersensitivity pneumonitis is an environmentally -induced diffuse parenchymal lung disease. In addition to hypersensitivity pneumonitis, domestic and occupational exposures have been shown to influence onset and progression of other ILDs, including idiopathic interstitial pneumonias such as idiopathic pulmonary fibrosis. A key component of the clinical evaluation of patients presenting with ILD includes elucidation of a complete exposure history, which may influence diagnostic classification of the ILD as well as its management. Currently, there is no standardized approach to environmental evaluation or remediation of potentially harmful exposures in home or workplace environments for patients with ILD. This review discusses evidence for environmental contributions to ILD pathogenesis and draws on asthma and occupational medicine literature to frame the potential utility of a professional evaluation for environmental factors contributing to the development and progression of ILD. Although several reports suggest benefits of environmental assessment for those with asthma or certain occupational exposures, lack of information about benefits in broader populations may limit application. Determining the feasibility, long-term outcomes, and cost-effectiveness of environmental evaluation and remediation in acute and chronic ILDs should be a focus of future research.

Citing Articles

Identification of early genes in the pathophysiology of fibrotic interstitial lung disease in a new model of pulmonary fibrosis.

Hennion N, Bedart C, Vandomber L, Gottrand F, Humez S, Chenivesse C Cell Mol Life Sci. 2025; 82(1):115.

PMID: 40074941 PMC: 11904048. DOI: 10.1007/s00018-025-05620-0.


Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: current perspectives.

Cottin V, Martinez F, Smith V, Walsh S Eur Respir Rev. 2024; 31(165).

PMID: 38743511 PMC: 9724802. DOI: 10.1183/16000617.0003-2022.


Diagnosis and Pharmacologic Management of Fibrotic Interstitial Lung Disease.

Berger K, Kaner R Life (Basel). 2023; 13(3).

PMID: 36983755 PMC: 10055741. DOI: 10.3390/life13030599.


The Association between Exposures and Disease Characteristics in Familial Pulmonary Fibrosis.

Copeland C, Donnelly E, Mehrad M, Ding G, Markin C, Douglas K Ann Am Thorac Soc. 2022; 19(12):2003-2012.

PMID: 35877079 PMC: 9743479. DOI: 10.1513/AnnalsATS.202203-267OC.


Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease.

Todd N, Atamas S, Hines S, Luzina I, Shah N, Britt E Expert Rev Respir Med. 2022; 16(2):235-245.

PMID: 35034567 PMC: 8983480. DOI: 10.1080/17476348.2022.2030710.

References
1.
Hendrick D, Marshall R, Faux J, Krall J . Protective value of dust respirators in extrinsic allergic alveolitis: clinical assessment using inhalation provocation tests. Thorax. 1981; 36(12):917-21. PMC: 471860. DOI: 10.1136/thx.36.12.917. View

2.
Quirce S, Vandenplas O, Campo P, Cruz M, de Blay F, Koschel D . Occupational hypersensitivity pneumonitis: an EAACI position paper. Allergy. 2016; 71(6):765-79. DOI: 10.1111/all.12866. View

3.
Kennedy S, Le Moual N, Choudat D, Kauffmann F . Development of an asthma specific job exposure matrix and its application in the epidemiological study of genetics and environment in asthma (EGEA). Occup Environ Med. 2000; 57(9):635-41. PMC: 1740014. DOI: 10.1136/oem.57.9.635. View

4.
Fernandez Perez E, Swigris J, Forssen A, Tourin O, Solomon J, Huie T . Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest. 2013; 144(5):1644-1651. PMC: 4694094. DOI: 10.1378/chest.12-2685. View

5.
Conti S, Harari S, Caminati A, Zanobetti A, Schwartz J, Bertazzi P . The association between air pollution and the incidence of idiopathic pulmonary fibrosis in Northern Italy. Eur Respir J. 2018; 51(1). DOI: 10.1183/13993003.00397-2017. View